Mark A. Sr Prygocki

Insider Reports History

Entity
Individual
Location
C/O Medics, 8125 N. Hayden Rd, Scottsdale, AZ
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark A. Sr Prygocki:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Verrica Pharmaceuticals Inc. Director Stock Option (right to buy) 20K Jun 6, 2024 Direct
Clarus Therapeutics Holdings, Inc. Director Common Stock 5.77K Jun 7, 2022 Direct
Clarus Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 4.81K Jun 7, 2022 Direct

Insider Reports Filed by Mark A. Sr Prygocki

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRCA Verrica Pharmaceuticals Inc. Jun 6, 2024 1 $0 4 Jun 7, 2024 Director
VRCA Verrica Pharmaceuticals Inc. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
VRCA Verrica Pharmaceuticals Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
CRXT Clarus Therapeutics Holdings, Inc. Jun 7, 2022 2 $0 4 Jun 9, 2022 Director
CRXT Clarus Therapeutics Holdings, Inc. Dec 12, 2021 2 $0 4 Dec 14, 2021 Director
CRXT Clarus Therapeutics Holdings, Inc. Sep 9, 2021 0 $0 3 Sep 13, 2021 Director
VRCA Verrica Pharmaceuticals Inc. Jun 10, 2021 1 $0 4/A Jun 17, 2021 Director